At the end of October, fill rates for Tamiflu were at 0.33 percent, and in the week since, that has jumped to 0.59 percent.
Seven drugmakers have reported they’re short on Tamiflu’s generic, oseltamivir, according to the American Society of Health-System Pharmacists’ drug shortage website.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
